| Document Date: 2015-04-09 13:04:46
Open Document File Size: 301,96 KBShare Result on Facebook
City Milano / Mangelsdorf / Ghyselinck / / Company Mitsui / Santa Cruz Biotechnology Inc. / Pearson / BP / Gibco-BRL-Life Technologies / Sigma-Aldrich / Amersham / Cell Signaling Technology Inc. (USA) / G. and PlataniasL.C. / mCi / Bristol-Myers Squibb / / Country France / United States / Italy / / Currency pence / cent / / / Event FDA Phase / / Facility Centre National / / IndustryTerm surveillance machinery / transcription machinery / chemicals / / MedicalCondition DF / Cancer / embryonal carcinoma / sur le Cancer / ts85 mouse mammary carcinoma / mammary carcinoma / / MedicalTreatment chemoprevention / / Organization Centre National / HoÃpital Universitaire de Strasbourg / Institut National / / Person Finley / Chen / Mario Negri / Jean-Luc Plassat / Heard / / Position DR5-tkCAT reporter / author / putative transcriptional mediator / RT / DR5-tk-CAT reporter / WB / reporter / D.J. / SYBR Green Light-Cycler / / Product Tora / vitamin D / vitamin A / RPG / PD98059 / / ProvinceOrState South Dakota / New Brunswick / P.N. / / PublishedMedium la Recherche / / SportsLeague AF2 / / Technology alpha / antibodies / DNA binding / gel electrophoresis / CAT / /
SocialTag |
The EMBO Journal Vol. 21 No. 14 pp. 3760±3769, 2002 Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RARg degradation and transactivation Maurizio GiannõÁ1,2, Annie Bauer1,